Pharmaceutical sciences have evolved through the dynamic integration of chemistry and bioscience, progressing from traditional therapeutic approaches to advanced biopharmaceuticals and next-generation drug delivery systems. In today’s innovation-driven landscape, translational development plays a critical role in transforming scientific discoveries into safe, effective, and accessible therapeutics, with regulatory science serving as a key enabler of this process. This proposal for a comprehensive conference titled “Pharma Technology & Translational Development: Integrating Chemistry, Bioscience and Regulatory for Next-Gen Therapeutics – 2026” intends to bring together academicians, researchers, industry experts, clinicians, and regulatory professionals to explore emerging pharmaceutical technologies and translational strategies. The event aims to foster interdisciplinary collaboration, address translational and regulatory challenges, and promote innovation aligned with global standards and public health priorities.